- Early detection has now made it possible for the patients to maintain remission and to manage this chronic state with a good quality of life.
The global incidence rate of inflammatory bowel diseases (IBD) has increased from 1990 to 2021 according to the numbers of global stress on the disease organization with an increasing trend in Asian countries, which requires immediate attention. Thanks to the awareness created worldwide, there is now early detection methods, improved management and new treatments to relieve the disease. On a conference (IBD Nexus) organized by Takeda, a global biopharmaceutical director, which is committed to the further development of patient care and one of the stakeholders in the therapeutic area of the therapeutic area of inflammatory intestinal diseases (IBD), many health professions and gastroenterologists from all over the world, which are in global combination and in the worldwide combination Interventions in which epidemiology, symptoms, symptoms, symptoms, symptoms, symptoms, symptoms, the symptoms, the symptoms, the DOB.
Dr. Badr al-Bawardy, MD, an important gastroenterologist who specialized in the management of IBD in the King Faisal Specialist Hospital and Research Center in Riad, Saudi Arabia and Adjunct Faculties at Yale University, was a delegate of the IBD-Nexus event, speaks in terms of etymology, treatment and management the disease.
Dr. Badr Al Bawardy, MD
Gastroenterologist in the King Faisal Specialist Hospital and Research Center
Dr. Al-Bawardy received his MD with award from George Washington University. After the medical faculty, he completed internal medicine, a gastroenterology grant and a specialized scholarship for inflammatory bowel diseases in the Mayo clinic in Rochester, MN, which gave him valuable experience with the treatment of the disease alongside leaders.
What is inflammatory bowel diseases (IBD)? Can you explain it in more detail?
IBD is a roof term that refers to two diseases, including ulcerative colitis (UC) and Crohn’s disease, which have many similarities and few differences. Both are considered autoimmune conditions. While ulcerative colitis only affects the colon, Crohn’s disease can affect part of the stomach intestine tract. The earlier it can be recorded, diagnosed and treated appropriately, the higher the likelihood of bringing the disease into remission.
What causes IBD?
The exact cause of IBD is unknown. It is believed that it is related to genetic and environmental factors that trigger the body’s immune system to self-fitting the gastrointestinal tract. Environmental factors associated with IBD include smoking, early exposure to antibiotics and certain nutritional patterns.
How is IBD diagnosed?
Many of the IBD symptoms for UC and CD are common like:
- Get abdominal pain
- Diarrhea
- Blood passing into stool fever
- Weight loss
Some of these symptoms can occur among other diseases such as food poisoning or other infections, and therefore individuals tend to delay the diagnosis. We recommend that an individual often experiences abdominal pain, diarrhea, blood in the stool, etc., seek help with your family doctor, who can then recommend specialists and also tests such as blood tests, chair tests, colonoscopy with biopsy with biopsy, different types of endoscopy, the upper endoscopy, which is as early as possible, as possible, as possible, as possible, as possible Location, as possible, as possible, as possible, are able to go to the patient with regard to the steam system, to the Dabbertos, Dabbertos, DabbertosLed.
Who is at risk?
The disease is often diagnosed in the Caucasian population in Canada, Great Britain, parts of Europe, the USA and Australia. However, there is now also indications of increasing incidence in Asian countries.
Please tell us about the IBD Nexus Summit and how this initiative from Takeda will draw attention to IBD?
I think this conference – the IBD Nexus Summit, is a great initiative in Takeda to bring in so many doctors and gastroenterologists in the region under one roof in order to sharpen awareness of the increasing incidence, new treatments and insights into the treatment of this state. The conference made it possible for several IBD experts from different parts of the region to exchange collective experiences and learn from each other.
What role does stress and sitting lifestyle play, poor nutrition in tightening the condition?
IBD is a multifactorial disease that is due to a genetic assessment and environmental factors. Although the disease can be controlled well, relapses in which the disease becomes active and symptoms cause symptoms. Torches of the disease were associated with nutritional patterns, including a high absorption of processed foods, stress or anxiety, intestinal infections and certain medication. An overall healthy lifestyle together with compliance with medication and the closing of the treating gastroenterologist can limit the periods in which the disease becomes active and causes symptoms.
Many people think that they have to be diagnosed with IBD that they have to live with it. Is there a surgical intervention or immune modulator /biological treatment that can solve the disease?
IBD is a chronic disease in which early detection and intervention of the disease can help to go into the remission and minimize all torches. Although the disease is chronic, there are now several different treatment modalities that can bring the disease into a complete remission (a state in which the disease is inactive and does not cause symptoms). This includes medication such as those that regulate the immune system including biologics. In addition, a surgical excision of the inflamed part of the colon or the small intestine is sometimes required.
It is favorable if patients who were diagnosed with IBD are regularly in contact with their doctor, regularly monitoring and screening such as blood tests, scans including intestinal ultrasound and, as needed, colonoscopy. It is even more important that IBD is a complex illness and requires a team of specialists, including but not limited to gastroenterologists, surgeons, nutritionists and pharmacists who work closely together to offer patients with IBD the best care.